I always come back to the CVS, even though the pharmacy feels like the gate for an overbooked flight, and even though the ...

CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

GUILFORD — The wait will soon be over, the much-anticipated Target is set to open Aug. 17 at the Big Y Plaza, taking over the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

Nichols & Pratt Advisers sold 7,627 CVS Health shares in Q1, lowering its stake by 6.9%, SEC filings show. The firm now holds ...